SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-044828
Filing Date
2012-08-13
Accepted
2012-08-13 15:15:05
Documents
5
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v319342_10q.htm 10-Q 830213
2 EXHIBIT 31.1 v319342_ex31-1.htm EX-31.1 7177
3 EXHIBIT 31.2 v319342_ex31-2.htm EX-31.2 7027
4 EXHIBIT 32.1 v319342_ex32-1.htm EX-32.1 3325
5 EXHIBIT 32.2 v319342_ex32-2.htm EX-32.2 3261
  Complete submission text file 0001144204-12-044828.txt   852359
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54365 | Film No.: 121027382
SIC: 2836 Biological Products, (No Diagnostic Substances)